HUE059593T2 - Rekombináns hGH-t tartalmazó gyógyszerkészítmény növekedési hormon hiányának kezelésére - Google Patents
Rekombináns hGH-t tartalmazó gyógyszerkészítmény növekedési hormon hiányának kezeléséreInfo
- Publication number
- HUE059593T2 HUE059593T2 HUE17753492A HUE17753492A HUE059593T2 HU E059593 T2 HUE059593 T2 HU E059593T2 HU E17753492 A HUE17753492 A HU E17753492A HU E17753492 A HUE17753492 A HU E17753492A HU E059593 T2 HUE059593 T2 HU E059593T2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- pharmaceutical composition
- growth hormone
- hormone deficiency
- recombinant hgh
- Prior art date
Links
- 206010056438 Growth hormone deficiency Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160018695 | 2016-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE059593T2 true HUE059593T2 (hu) | 2022-12-28 |
Family
ID=59761652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17753492A HUE059593T2 (hu) | 2016-02-17 | 2017-02-16 | Rekombináns hGH-t tartalmazó gyógyszerkészítmény növekedési hormon hiányának kezelésére |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210177945A1 (hu) |
| EP (1) | EP3416677B1 (hu) |
| JP (1) | JP6896749B2 (hu) |
| KR (2) | KR20170096968A (hu) |
| CN (1) | CN109152816B (hu) |
| BR (1) | BR112018016817A2 (hu) |
| CA (1) | CA3014164A1 (hu) |
| DK (1) | DK3416677T3 (hu) |
| ES (1) | ES2925901T3 (hu) |
| HU (1) | HUE059593T2 (hu) |
| JO (1) | JOP20170044B1 (hu) |
| PL (1) | PL3416677T3 (hu) |
| PT (1) | PT3416677T (hu) |
| RU (1) | RU2732113C2 (hu) |
| TW (1) | TWI748990B (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114874333A (zh) * | 2021-10-18 | 2022-08-09 | 深圳科兴药业有限公司 | 一种生长激素融合蛋白及其应用 |
| AU2022399020A1 (en) | 2021-11-26 | 2024-06-13 | Genexine, Inc. | High concentration administration formulation of hgh fusion protein |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007289344B2 (en) * | 2006-08-31 | 2011-04-14 | Novartis Ag | Pharmaceutical compositions comprising hGH for oral delivery |
| KR101380732B1 (ko) * | 2007-05-30 | 2014-04-10 | 포항공과대학교 산학협력단 | 면역글로불린 융합 단백질 |
| CN102875683B (zh) * | 2011-07-11 | 2014-06-11 | 旭华（上海）生物研发中心有限公司 | 长效重组人生长激素的Fc融合蛋白 |
| NZ702557A (en) * | 2012-06-05 | 2017-06-30 | Amunix Operating Inc | Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency |
| KR20150124955A (ko) * | 2013-03-11 | 2015-11-06 | 아뮤닉스 오퍼레이팅 인코포레이티드 | 사람 성장 호르몬 유사체를 사용한 소아 성장 호르몬 결핍증의 치료 방법 |
| US20160015789A1 (en) * | 2014-07-17 | 2016-01-21 | Teva Pharmaceutical Industries, Ltd. | FORMULATIONS OF AN ALBUMIN hGH FUSION PROTEIN |
| WO2018044060A1 (en) * | 2016-08-30 | 2018-03-08 | Genexine,Inc. | PHARMACEUTICAL COMPOSITION FOR TREATING GROWTH HORMONE DEFICIENCY CONTAINING hGH FUSION PROTEIN |
-
2017
- 2017-02-16 JO JOP/2017/0044A patent/JOP20170044B1/ar active
- 2017-02-16 CA CA3014164A patent/CA3014164A1/en active Pending
- 2017-02-16 DK DK17753492.2T patent/DK3416677T3/da active
- 2017-02-16 PL PL17753492.2T patent/PL3416677T3/pl unknown
- 2017-02-16 HU HUE17753492A patent/HUE059593T2/hu unknown
- 2017-02-16 ES ES17753492T patent/ES2925901T3/es active Active
- 2017-02-16 EP EP17753492.2A patent/EP3416677B1/en active Active
- 2017-02-16 KR KR1020170021104A patent/KR20170096968A/ko not_active Application Discontinuation
- 2017-02-16 BR BR112018016817A patent/BR112018016817A2/pt unknown
- 2017-02-16 JP JP2018543675A patent/JP6896749B2/ja active Active
- 2017-02-16 CN CN201780018326.9A patent/CN109152816B/zh active Active
- 2017-02-16 PT PT177534922T patent/PT3416677T/pt unknown
- 2017-02-16 US US16/077,177 patent/US20210177945A1/en active Pending
- 2017-02-16 RU RU2018132694A patent/RU2732113C2/ru active
- 2017-02-17 TW TW106105296A patent/TWI748990B/zh active
-
2018
- 2018-12-13 KR KR1020180161061A patent/KR102312986B1/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019508421A (ja) | 2019-03-28 |
| JP6896749B2 (ja) | 2021-06-30 |
| CA3014164A1 (en) | 2017-08-24 |
| RU2732113C2 (ru) | 2020-09-11 |
| CN109152816A (zh) | 2019-01-04 |
| KR20180135839A (ko) | 2018-12-21 |
| TW201729831A (zh) | 2017-09-01 |
| EP3416677B1 (en) | 2022-08-03 |
| PL3416677T3 (pl) | 2022-11-21 |
| DK3416677T3 (da) | 2022-08-29 |
| RU2018132694A3 (hu) | 2020-03-17 |
| TWI748990B (zh) | 2021-12-11 |
| EP3416677A4 (en) | 2019-11-06 |
| JOP20170044B1 (ar) | 2021-08-17 |
| BR112018016817A2 (pt) | 2018-12-26 |
| RU2018132694A (ru) | 2020-03-17 |
| EP3416677A1 (en) | 2018-12-26 |
| ES2925901T3 (es) | 2022-10-20 |
| CN109152816B (zh) | 2022-08-16 |
| PT3416677T (pt) | 2022-09-06 |
| US20210177945A1 (en) | 2021-06-17 |
| KR20170096968A (ko) | 2017-08-25 |
| KR102312986B1 (ko) | 2021-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276464A (en) | Methods and preparations for administering therapeutic protein | |
| PL3785733T3 (pl) | Kompozycja farmaceutyczna do leczenia autyzmu | |
| IL286592B (en) | Amino acid compounds for the treatment of liver disease | |
| IL262568A (en) | Inactive material based on proteins for active pharmaceutical ingredients | |
| HK1232242A1 (zh) | 用於癌症靶向治療的包含基於重組血紅蛋白蛋白質或亞基的治療劑的藥物組合物 | |
| EP3362048A4 (en) | COMPOSITION FOR INTRAORAL ADMINISTRATION OF PEPTIDES AND BIOLOGICALLY ACTIVE PROTEINS | |
| IL275525A (en) | A pharmaceutical preparation for the treatment of cancer | |
| PT3506923T (pt) | Composição farmacêutica para tratamento de deficiência de hormona de crescimento contendo proteína de fusão de hgh | |
| PL3416677T3 (pl) | Kompozycja farmaceutyczna obejmująca rekombinowany hgh do leczenia niedoboru hormonu wzrostu | |
| SI3731872T1 (sl) | Postopek za zagotavljanje sestavka PEGiliranih beljakovin | |
| HK1258040A1 (zh) | 包含重組人促甲狀腺激素的組合物以及生產重組人促甲狀腺激素的方法 | |
| EP3397267A4 (en) | PEPTIDES FOR THE TREATMENT OF RESORPTIVE BONE DISEASE | |
| SG11202105231UA (en) | Pharmaceutical composition for treating wounds | |
| HK1255586A1 (zh) | 含有多肽的醫藥組合物 | |
| IL279707A (en) | A pharmaceutical preparation that includes a polypeptide | |
| PT3785733T (pt) | Composição farmacêutica para o tratamento do autismo | |
| SG11202005990RA (en) | Process for providing pegylated protein composition | |
| PL3731873T3 (pl) | Sposób dostarczania kompozycji pegylowanego białka | |
| GB201814764D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| ZA201801788B (en) | Lysobactin for use in the treatment of bovine mastitis | |
| GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| EP3491012A4 (en) | TREATING ADULT GROWTH HORMONE WITH ANALOGUE OF HUMAN GROWTH HORMONE | |
| EP3253379A4 (en) | Pharmaceutical composition for the treatment of obesity |